why choose us

First received: April 04, 2024

Clinical Trial: Pharmacokinetics of Afamelanotide in EPP Patients

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Erythropoietic Protoporphyria

Study Type: INTERVENTIONAL


Official Title: A Study to Evaluate the Pharmacokinetics of Afamelanotide in Patients With Erythropoietic Protoporphyria (EPP)

Brief Summary: The purpose of this study is to evaluate the concentration of afamelanotide in serum after the administration of afamelanotide in adolescent and adult EPP patients.

Read more